GDRX icon

GoodRx Holdings

163 hedge funds and large institutions have $342M invested in GoodRx Holdings in 2026 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 51 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $2.95M | Put options by funds: $1.47M

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

21% more capital inflows, than outflows

Capital inflows: $17.7M | Capital outflows: $14.6M

0.46% more ownership

Funds ownership: 108.91% → 109.37% (+0.46%)

2% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 51

8% less funds holding

Funds holding: 177 → 163 (-14)

41% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 27

Holders
163
Holders Change
-14
Holders Change %
-7.91%
% of All Funds
1.95%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
16
Increased
50
Reduced
51
Closed
27
Calls
$2.95M
Puts
$1.47M
Net Calls
+$1.48M
Net Calls Change
+$29K

GDRX Hedge Fund Activity: Q2 2026 in Review

163 of the 8,352 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2026, worth a combined $342M — up 48% from $232M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of GDRX and 16 opened new positions — a net loss of 11 holders — while 51 trimmed existing stakes and 50 added.

The largest buyer was Jane Street, adding an estimated $4.23M. The largest seller was Moore Capital Management, cutting an estimated $1.69M.

  • 163 institutional investors held GoodRx Holdings (GDRX) as of Q2 2026, down from 177 in Q1 2026.
  • Funds reported $342M of GoodRx Holdings stock for Q2 2026, up 48% quarter-over-quarter.
  • 16 funds opened new GoodRx Holdings positions in Q2 2026 and 27 closed out, a net change of -11 holders.
  • The largest GoodRx Holdings buyer in Q2 2026 was Jane Street, an estimated $4.23M added.
  • The largest GoodRx Holdings seller in Q2 2026 was Moore Capital Management, an estimated $1.69M sold.

Based on aggregated 13F filings for Q2 2026.